Related Experiment Video
Updated: Feb 17, 2026
miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
Exosomal miR-141-3p regulates osteoblast activity to promote the osteoblastic metastasis of prostate cancer
Yun Ye1,2, Su-Liang Li2, Yue-Yun Ma1
1Department of Laboratory Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710032, China.
Abstract:
Exosomes from cancer cells, which contain microRNA and reach metastasis loci prior to cancer cells, stimulate the formation of a metastatic microenvironment. Previous studies have shown that exosomal miR-141-3p is associated with metastatic prostate cancer (PCa). However, the role and regulatory mechanism of miR-141-3p in the microenvironment of bone metastases require further study. In this study, we performed a series of experiments in vivo and in vitro to determine whether exosomal miR-141-3p from MDA PCa 2b cells regulates osteoblast activity to promote osteoblastic metastasis. We demonstrate that extracts obtained from cell culture supernatants contained exosomes and that miR-141-3p levels were significantly higher in MDA PCa 2b cell exosomes. Via confocal imaging, numerous MDA PCa 2b exosomes were observed to enter osteoblasts, and miR-141-3p was transferred to osteoblasts through MDA PCa 2b exosomes in vitro. Exosomal miR-141-3p from MDA PCa 2b promoted osteoblast activity and increased osteoprotegerin OPG expression. miR-141-3p suppressed the protein levels of the target gene DLC1, indicating its functional significance in activating the p38MAPK pathway. In animal experiments, exosomal miR-141-3p had bone-target specificity and promoted osteoblast activity. Mice injected with miR-141-3p-mimics exosomes developed apparent osteoblastic bone metastasis. Exosomal miR-141-3p from MDA PCa 2b cells promoted osteoblast activity and regulated the microenvironment of bone metastases, which plays an important role in the formation of bone metastases and osteogenesis damage in PCa. Clarifying the specific mechanism of bone metastasis will help generate new possibilities for the treatment of PCa.
Insights
Exosomes carrying miR-141-3p from prostate cancer cells promote bone metastasis by stimulating osteoblast activity. This microRNA transfer to osteoblasts drives the formation of a pro-metastatic microenvironment.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Exosomes mediate intercellular communication and contribute to cancer metastasis.
- Exosomal microRNA-141-3p is linked to metastatic prostate cancer (PCa).
- The precise role of miR-141-3p in the bone metastatic microenvironment is not fully understood.
Purpose of the Study:
- To investigate if exosomal miR-141-3p from prostate cancer cells (MDA PCa 2b) regulates osteoblast activity to promote osteoblastic bone metastasis.
- To elucidate the mechanism by which miR-141-3p influences the bone microenvironment in PCa metastasis.
Main Methods:
- In vitro studies involving cell culture supernatants, exosome isolation, and confocal imaging to track exosome uptake by osteoblasts.
- Analysis of miR-141-3p levels in exosomes and its transfer to osteoblasts.
- In vivo animal experiments using mice injected with exosomes to assess bone metastasis and osteoblast activity.
- Western blot analysis to determine protein levels of target genes (e.g., DLC1) and assessment of signaling pathways (p38MAPK).
Main Results:
- MDA PCa 2b cell-derived exosomes were found to be enriched with miR-141-3p.
- Exosomes were successfully transferred to osteoblasts in vitro, delivering miR-141-3p.
- Exosomal miR-141-3p significantly promoted osteoblast activity and increased osteoprotegerin (OPG) expression.
- miR-141-3p suppressed DLC1 protein levels, activating the p38MAPK pathway.
- In vivo studies confirmed the bone-targeting specificity of exosomal miR-141-3p and its role in promoting osteoblastic bone metastasis.
Conclusions:
- Exosomal miR-141-3p derived from prostate cancer cells actively promotes osteoblast activity.
- This microRNA plays a critical role in regulating the bone metastatic microenvironment, contributing to osteogenesis damage in PCa.
- Understanding this mechanism offers potential new therapeutic strategies for treating prostate cancer bone metastasis.
Related Concept Videos
01:22MicroRNAs
01:22MicroRNAs
02:30Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
01:31Osteoclasts in Bone Remodeling